Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease

Doucet, Mariève, Russell, Aaron, Léger, Bertrand, Debigare, Richard, Joanisse, Denis R., Caron, Marc-André, LeBlanc, Pierre and Maltais, François 2007, Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease, American journal of respiratory and critical care medicine, vol. 176, no. 3, pp. 261-269.

Attached Files
Name Description MIMEType Size Downloads

Title Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease
Author(s) Doucet, Mariève
Russell, Aaron
Léger, Bertrand
Debigare, Richard
Joanisse, Denis R.
Caron, Marc-André
LeBlanc, Pierre
Maltais, François
Journal name American journal of respiratory and critical care medicine
Volume number 176
Issue number 3
Start page 261
End page 269
Publisher American Thoracic Society
Place of publication New York, N. Y.
Publication date 2007-05-03
ISSN 1073-449X
1535-4970
Keyword(s) chronic obstructive pulmonary disease
E3-ligases
forkhead box class O-1
AKT
muscle wasting
Summary Rationale: The molecular mechanisms of muscle atrophy in chronic obstructive pulmonary disease (COPD) are poorly understood. In wasted animals, muscle mass is regulated by several AKT-related signaling pathways.
Objectives: To measure the protein expression of AKT, forkhead box class O (FoxO)-1 and -3, atrogin-1, the phosphophrylated form of AKT, p70S6K glycogen synthase kinase-3ß (GSK-3ß), eukaryotic translation initiation factor 4E binding protein-1 (4E-BP1), and the mRNA expression of atrogin-1, muscle ring finger (MuRF) protein 1, and FoxO-1 and -3 in the quadriceps of 12 patients with COPD with muscle atrophy and 10 healthy control subjects. Five patients with COPD with preserved muscle mass were subsequently recruited and were compared with six patients with low muscle mass.
Methods: Protein contents and mRNA expression were measured by Western blot and quantitative polymerase chain reaction, respectively.
Measurements and Main Results: The levels of atrogin-1 and MuRF1 mRNA, and of phosphorylated AKT and 4E-BP1 and FoxO-1 proteins, were increased in patients with COPD with muscle atrophy compared with healthy control subjects, whereas atrogin-1, p70S6K, GSK-3ß, and FoxO-3 protein levels were similar. Patients with COPD with muscle atrophy showed an increased expression of p70S6K, GSK-3ß, and 4E-BP1 compared with patients with COPD with preserved muscle mass.
Conclusions: An increase in atrogin-1 and MuRF1 mRNA and FoxO-1 protein content was observed in the quadriceps of patients with COPD. The transcriptional regulation of atrogin-1 and MuRF1 may occur via FoxO-1, but independently of AKT. The overexpression of the muscle hypertrophic signaling pathways found in patients with COPD with muscle atrophy could represent an attempt to restore muscle mass.
Language eng
Field of Research 060105 Cell Neurochemistry
Socio Economic Objective 970106 Expanding Knowledge in the Biological Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2007, American Thoracic Society
Persistent URL http://hdl.handle.net/10536/DRO/DU:30007524

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 95 times in TR Web of Science
Scopus Citation Count Cited 105 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 494 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Mon, 29 Sep 2008, 08:53:06 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.